Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319

BACKGROUND: Chordoma was a typically slow-growing tumor. The therapeutic approach to chordoma had traditionally relied mainly on surgical therapy. And the main reason for therapeutic failure was resistance to chemotherapy and radiotherapy. However the refractory mechanism was not clear. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Zhengang, Long, Hua, Hu, Yunsheng, Qiu, Xiuchun, Chen, Xiang, Li, Zhao, Fan, Degang, Ma, Baoan, Fan, Qingyu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017037/
https://www.ncbi.nlm.nih.gov/pubmed/21143841
http://dx.doi.org/10.1186/1756-9966-29-158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017037/
https://www.ncbi.nlm.nih.gov/pubmed/21143841
http://dx.doi.org/10.1186/1756-9966-29-158

Ejemplares similares